LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 99 filers reported holding LYELL IMMUNOPHARMA INC in Q2 2023. The put-call ratio across all filers is 11.33 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $56,524 | -48.3% | 38,982 | -20.4% | 0.00% | – |
| Q1 2024 | $109,240 | +25.6% | 48,986 | +9.3% | 0.00% | – |
| Q4 2023 | $86,942 | +51.8% | 44,816 | +15.0% | 0.00% | – |
| Q3 2023 | $57,266 | -53.5% | 38,957 | +0.6% | 0.00% | – |
| Q2 2023 | $123,132 | +38.5% | 38,721 | +2.8% | 0.00% | – |
| Q1 2023 | $88,904 | -40.3% | 37,671 | -12.2% | 0.00% | -100.0% |
| Q4 2022 | $148,807 | -49.2% | 42,884 | +7.4% | 0.00% | 0.0% |
| Q3 2022 | $293,000 | +16.7% | 39,921 | +3.4% | 0.00% | 0.0% |
| Q2 2022 | $251,000 | -6.0% | 38,606 | -26.8% | 0.00% | 0.0% |
| Q1 2022 | $267,000 | -11.6% | 52,739 | +35.2% | 0.00% | 0.0% |
| Q4 2021 | $302,000 | – | 39,013 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WuXi AppTec Co., Ltd. | 7,682,156 | $11,139,126 | 47.74% |
| MWG Management Ltd. | 20,162,332 | $29,235,381 | 31.93% |
| Orland Properties Ltd | 15,093,969 | $21,886,255 | 16.63% |
| Foresite Capital Management IV, LLC | 8,325,000 | $12,071,250 | 8.11% |
| Opaleye Management Inc. | 1,670,000 | $2,421,500 | 0.55% |
| MIC Capital Management UK LLP | 1,740,569 | $2,523,825 | 0.55% |
| Alphabet Inc. | 5,865,125 | $8,504,431 | 0.43% |
| HSG Holding Ltd | 3,045,997 | $4,995,435 | 0.18% |
| Orbimed Advisors | 6,405,098 | $9,287,392 | 0.18% |
| Ikarian Capital, LLC | 526,066 | $762,796 | 0.13% |